These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6798554)

  • 1. [Sodium valproate, platelet dysfunction and bleeding (author's transl)].
    Loiseau P
    Nouv Presse Med; 1981 Dec; 10(46):3789-90. PubMed ID: 6798554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of sodium valproate (sodium di-N-propylacetate) on malonyldialdehyde-production and other platelet function tests.
    von Voss H; Schulte-Berbühl R; Göbel U
    Minerva Pediatr; 1978 Sep; 30(17):1397-404. PubMed ID: 375054
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe bleeding complications during antiepileptic treatment with valproic acid in children.
    Cannizzaro E; Albisetti M; Wohlrab G; Schmugge M
    Neuropediatrics; 2007 Feb; 38(1):42-5. PubMed ID: 17607605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium valproate, platelet dysfunction, and bleeding.
    Loiseau P
    Epilepsia; 1981 Apr; 22(2):141-6. PubMed ID: 6781890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
    Loisseau P; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
    [No Abstract]   [Full Text] [Related]  

  • 9. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia associated with sodium valproate treatment.
    Neophytides AN; Nutt JG; Lodish JR
    Ann Neurol; 1979 Apr; 5(4):389-90. PubMed ID: 375808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Valproate induced parkinsonism].
    Park-Matsumoto YC; Tazawa T
    No To Shinkei; 1998 Jan; 50(1):81-4. PubMed ID: 9493204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder.
    De Berardis D; Campanella D; Matera V; Gambi F; La Rovere R; Sepede G; Grimaldi MR; Pacilli AM; Salerno RM; Ferro FM
    J Clin Psychopharmacol; 2003 Oct; 23(5):451-8. PubMed ID: 14520121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sodium valproate (Na VPa) monotherapy in childhood epilepsy ].
    Dulac O; Steru D; Rey E; Arthuis M
    Arch Fr Pediatr; 1982; 39(6):347-52. PubMed ID: 6812534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
    Boggs JG; Preis K
    Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monotherapy with sodium valproate in generalized primary epilepsy. 2d phase: Study of long-term efficacy and tolerance].
    Feuerstein J; Revol M; Roger J; Sallou C; Truelle JL; Vercelletto P; Weber M
    Sem Hop; 1983 Apr; 59(16):1263-74. PubMed ID: 6191393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tolerance to and unwanted effects of valproate sodium].
    Despland PA
    Praxis (Bern 1994); 1994 Oct; 83(40):1132-9. PubMed ID: 7939085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC; Diener W; Kutschke G; Schneble HJ; Korinthenberg R; Sutor AH
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of valproic acid and sodium valproate (author's transl)].
    Sorel L; Rucquoy-Ponsar M; Willems C; Diepart E; Harmant J
    Acta Neurol Belg; 1981; 81(5):283-90. PubMed ID: 6797226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate.
    Rinnerthaler M; Luef G; Mueller J; Seppi K; Wissel J; Trinka E; Bauer G; Poewe W
    Epilepsia; 2005 Feb; 46(2):320-3. PubMed ID: 15679514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.